510(k) K213836
K213836 is an FDA 510(k) premarket notification submitted by Relievant Medsystems, Inc. for the device "Intracept Intraosseous Nerve Ablation System". The FDA issued a decision of Substantially Equivalent on Mar 11, 2022. The device falls under product code GXI (Probe, Radiofrequency Lesion), a Class II device regulated under 21 CFR 882.4725. Relievant Medsystems, Inc. has 9 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 11, 2022
- Date Received
- Dec 9, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Probe, Radiofrequency Lesion
- Device Class
- Class II
- Regulation Number
- 882.4725
- Review Panel
- NE
- Submission Type
- 510(k)
Need the full FDA record for Relievant Medsystems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.